MONDAY, MAY 29, 2017

UNICEF asissts Zambia in cholera outbreak response

UNICEF recently provided the Zambian Ministry of Health with supplies worth $12,000 to aid in the response to an outbreak of cholera, which has so far seen 549 cases and four deaths. Read More »

NIH organizations issue report on Ebola patient's care

A new report from various organizations under the National Institutes of Health details the clinical course of a 34-year-old American with Ebola virus disease who received intensive supportive care through a clinical trial at the NIH Special Clinical Studies Unit. Read More »

Influenza vaccine could reduce risk of stillbirths

Mothers who receive seasonal influenza vaccinations may have a reduced chance of stillbirth according to a new study of midwife records for just over 58,000 births in Western Australia. Read More »

Wistar Institute research suggests strategies for combating Chikungunya virus

A Wistar Institute study recommends combating Chikungunya virus (CHIKV) through boosting the immune system by rapidly producing CHIKV antibodies as well as a traditional DNA-based vaccine. Read More »

Purdue team creates 3-D map of Zika virus

Purdue University researchers recently created a near-atomic level map of the Zika virus, which could spark vaccines, antiviral drugs, antibodies and a diagnostic test capable of differentiating Zika virus infections from dengue infections. Read More »

Scientists advance parameter selection, verification techniques in HIV model

In a paper recently published in SIAM Journal on Uncertainty Quantification, Mami Wentworth, Ralph Smith and H.T. Banks used robust parameter selection and verification techniques on a dynamic HIV model. Read More »

NIH commemorates World Tuberculosis Day

The National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health, recently released a statement verifying the organization’s commitment to researching, preventing and treating tuberculosis. Read More »

New vaginal lactobacillus for neutralizing HIV-1 antibody fragments

Scientists from Osel Inc. and their partners have engineered a vaginal lactobacillus that is designed to generate neutralizing antibody fragments against HIV-1 infections. Read More »

Study evaluates four-drug TB treatment for HIV/AIDS patients

Johns Hopkins University School of Medicine, the University of North Carolina, and the University of Pennsylvania researchers recently published a report stating there is not any additional benefit for advanced HIV/AIDS patients to receive four tuberculosis drugs in lieu of isonazid alone. Read More »

International team collaborates in fight against drug-resistant malaria

A team of scientists from Stanford University, the Universities of Melbourne, the Medical Research Council in Cambridge, and the University of California, San Francisco have made a significant breakthrough in finding first-defense treatments for the growing resistance of malaria parasites. Read More »

Scientists develop alternative for Ebola screening program

A study recently published in Preventive Medicine shows a potential alternative that scientists have developed to replace the Ebola entry screen program that is in place at U.S. airports. Read More »

New drug combinations may expedite TB treatments

Scientists from Shanghai Jiano Tong University and UCLA have created a novel combination of drugs that could shorten the amount of time that tuberculosis patients undergo treatment. Read More »

WHO director-general releases statement about Zika virus

Dr. Margaret Chan, the director-general of the World Health Organization (WHO), recently released a statement about the outbreak of the Zika virus, which has continued to be an ongoing problem since Feb. 1. Read More »

Seasonal flu vaccine matches New Mexico strains

The New Mexico Department of Health recently confirmed that the seasonal influenza vaccine is a positive match for the strains that are currently circulating, adequately protecting people from contracting the influenza virus. Read More »

University of Georgia, Sanofi Pasteur researchers design new H1N1 influenza vaccine

Scientists at the University of Georgia and Sanofi Pasteur, which is the vaccines division of Sanofi, recently developed a new vaccine to protect people from H1N1 influenza. Read More »

Simulation demonstrates pandemic swine flu had minor effect in Finland

Scientists recently used a simulation model to demonstrate the true effects of various infectious disease in an area, with the pandemic swine flu and its minor effects on Finland. Read More »

Global health community marks World Tuberculosis Day

To mark World Tuberculosis Day Thursday, the global health community honored discoveries from scientists who have made TB discoveries throughout history, including Robert Koch. Read More »

New discoveries show promise for AIDS vaccine

Researchers from The Scripps Research Institute (TSRI), the International AIDS Vaccine Initiative (IAVI) and the La Jolla Institute for Allergy and Immunology recently discovered that an engineered vaccine protein bonds with important immune cells that are available in almost all humans, potentially helping create HIV antibodies naturally. Read More »

New Ebola group found in Guinea

Scientists recently discovered a new cluster of the Ebola virus in Guinea, as there were three unexplained deaths in Korokpara village, located in N’Zerekore prefecture, during the last few seeks. Read More »

Curcumin may help fight drug-resistant tuberculosis

Curcumin, which is found in turmeric and is one of the major elements in curry powder, may be able to help treat people who have infections of drug-resistant tuberculosis. Read More »